UHTUNIVERSAL HEALTH REALTY INCOME TRUST(UHT)Stock Analysis

AI analysis on 2,800+ stocks →
Real EstateNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 798783UHT stock profile & AI dashboard →

13F Pro Quality Score

54.6/100

Rank #1,205 of 2,879 stocksTOP 50%

View Real Estate peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

37.4/100

Profitability

81.2/100

Balance Sheet

59.7/100

Earnings Quality

44.3/100

Free Cash Flow

92.3/100

Institutional Flow

6.0/100

Revenue Scale

17.6/100

Dilution Risk

58.4/100

UHT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for UNIVERSAL HEALTH REALTY INCOME TRUST (UHT), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores UHT at 54.6/100 on a 32-signal composite quality model, placing it at rank #1,205 of 2,879 stocks — the top half of the AI-ranked universe. UHT scores in the top quartile across free cash flow (92.3), profitability (81.2). Areas of concern include institutional flow (6.0) and revenue scale (17.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), UNIVERSAL HEALTH REALTY INCOME TRUST reports quarterly revenue of $24.5M, net income of $5.0M, free cash flow of $11.9M. Top institutional holders of UHT by reported 13-F value include BlackRock,, STATE STREET, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. UHT trades on the NYSE exchange and files with the SEC under CIK 798783. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UHT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UNIVERSAL HEALTH REALTY INCOME TRUST directly from SEC EDGAR. UNIVERSAL HEALTH REALTY INCOME TRUST's 13F Pro composite quality score has ranged between 55 and 58 since 2026, currently 54.6 — a declining long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q1 2026

$24.5M

Net Income

Q1 2026

$5.0M

Free Cash Flow

Q1 2026

$11.9M

ROIC

Q1 2026

6.1%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.6% YoY
$99.0MFY 2024
FY21 $84.2MFY22 $90.6MFY23 $95.6MFY24 $99.0M

Net Income

+24.9% YoY
$19.2MFY 2024
FY21 $109.2MFY22 $21.1MFY23 $15.4MFY24 $19.2M

Operating Income

+17.4% YoY
$36.8MFY 2024
FY21 $28.9MFY22 $30.7MFY23 $31.3MFY24 $36.8M

EPS (Diluted)

+25.2% YoY
$1.39FY 2024
FY21 $7.92FY22 $1.53FY23 $1.11FY24 $1.39

Total Assets

-2.6% YoY
$580.9MFY 2024
FY21 $598.4MFY22 $607.5MFY23 $596.4MFY24 $580.9M

Total Debt

+2.4% YoY
$368.4MFY 2024
FY21 $329.1MFY22 $343.1MFY23 $359.7MFY24 $368.4M

Op. Cash Flow

+9.3% YoY
$46.9MFY 2024
FY21 $47.7MFY22 $46.8MFY23 $42.9MFY24 $46.9M

AI Insight: UHT Financial Trends

Equity has eroded 23% over eight quarters while revenue is flat and debt crept to $375M — balance sheet deterioration is the dominant theme.

Revenue has been essentially flat, ranging $24M–$25M across all eight quarters with no discernible growth.

Equity declined steadily from $191M in Q2 2024 to $148M in Q1 2026, a $43M or ~23% erosion.

Total debt rose from $368M in Q4 2024 to $375M in Q4 2025, while equity shrank — implying rising leverage.

Operating cash flow has oscillated between $10M and $14M with no clear upward trend.

Continued equity erosion with flat revenue raises the risk of a materially weakened balance sheet if debt levels hold or rise.

Operating income slipped from $10M in Q2 2024 to $8M in Q3 2025 and Q4 2025 — monitor for further compression.

Total debt data is only available for Q4 2024 and Q4 2025; interim leverage visibility is limited.

AI Insight: UHT Ratio Trends

Q1 2026 shows a broad margin and returns recovery, but year-end ROIC collapses to single digits in back-to-back Q4s signal a recurring seasonal drag.

Operating margin rebounded to 36.5% in Q1 2026 after troughing at 33.2% in Q3 2025, near the two-year low.

ROE improved to 13.6% in Q1 2026, the highest single-quarter reading in the dataset, up from 10.1% in Q3 2025.

ROIC collapsed to 6.4% in Q4 2025 and 6.8% in Q4 2024, versus 21–24% in other quarters — a sharp, recurring year-end pattern.

D/E rose from 2.05 in Q4 2024 to 2.46 in Q4 2025, the only two quarters with leverage data available.

Back-to-back Q4 ROIC crashes (6.8%, 6.4%) warrant scrutiny — whether structural, accounting-driven, or seasonal needs clarification.

D/E ticked up 0.41 turns year-over-year in Q4; continued leverage creep into Q4 2026 would pressure the balance sheet.

NPM recovery to 20.5% in Q1 2026 is encouraging; sustaining above 18% through Q3 2026 would confirm a trend improvement.

Get alerted when UHT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UNIVERSAL HEALTH REALTY INCOME TRUST including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put UHT on your watchlist

Track score changes the day UNIVERSAL HEALTH REALTY INCOME TRUST files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is UHT a good stock to buy?

13F Pro's AI-powered analysis of UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UHT are available on the UHT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own UHT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UHT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UNIVERSAL HEALTH REALTY INCOME TRUST's investment landscape.